Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100


Generation and analysis of genetically defined liver carcinomas derived from bipotential liver progenitors.

Zender L, Xue W, Cordón-Cardo C, Hannon GJ, Lucito R, Powers S, Flemming P, Spector MS, Lowe SW.

Cold Spring Harb Symp Quant Biol. 2005;70:251-61.


CRISPR-mediated direct mutation of cancer genes in the mouse liver.

Xue W, Chen S, Yin H, Tammela T, Papagiannakopoulos T, Joshi NS, Cai W, Yang G, Bronson R, Crowley DG, Zhang F, Anderson DG, Sharp PA, Jacks T.

Nature. 2014 Oct 16;514(7522):380-4. doi: 10.1038/nature13589. Epub 2014 Aug 6.


Genomic modeling of tumor onset and progression in a mouse model of aggressive human liver cancer.

Coulouarn C, Factor VM, Conner EA, Thorgeirsson SS.

Carcinogenesis. 2011 Oct;32(10):1434-40. doi: 10.1093/carcin/bgr133. Epub 2011 Jul 18.


Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J, Fan ST, Luk JM, Wigler M, Hannon GJ, Mu D, Lucito R, Powers S, Lowe SW.

Cell. 2006 Jun 30;125(7):1253-67.


Expression of retroviral sequences and oncogenes in murine hepatocellular tumors.

Dragani TA, Manenti G, Della Porta G, Gattoni-Celli S, Weinstein IB.

Cancer Res. 1986 Apr;46(4 Pt 2):1915-9.


Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis.

Barone M, Spano D, D'Apolito M, Centra M, Lasalandra C, Capasso M, Di Leo A, Volinia S, Arcelli D, Rosso N, Francavilla A, Tiribelli C, Iolascon A.

Mol Med. 2006 Apr-Jun;12(4-6):115-23.


β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma.

Mokkapati S, Niopek K, Huang L, Cunniff KJ, Ruteshouser EC, deCaestecker M, Finegold MJ, Huff V.

Cancer Res. 2014 Aug 15;74(16):4515-25. doi: 10.1158/0008-5472.CAN-13-3275. Epub 2014 May 21.


Expression profiling and identification of novel genes in hepatocellular carcinomas.

Graveel CR, Jatkoe T, Madore SJ, Holt AL, Farnham PJ.

Oncogene. 2001 May 10;20(21):2704-12.


Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer.

Lee SA, Ho C, Roy R, Kosinski C, Patil MA, Tward AD, Fridlyand J, Chen X.

Hepatology. 2008 Apr;47(4):1200-10. doi: 10.1002/hep.22169.


Liver-specific knockout of GRP94 in mice disrupts cell adhesion, activates liver progenitor cells, and accelerates liver tumorigenesis.

Chen WT, Tseng CC, Pfaffenbach K, Kanel G, Luo B, Stiles BL, Lee AS.

Hepatology. 2014 Mar;59(3):947-57. doi: 10.1002/hep.26711. Epub 2014 Jan 27.


Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury.

Kuhlmann WD, Peschke P.

Int J Exp Pathol. 2006 Oct;87(5):343-59.


Liver stem cells: implications for hepatocarcinogenesis.

Alison MR.

Stem Cell Rev. 2005;1(3):253-60. Review.


Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.

Holczbauer A, Factor VM, Andersen JB, Marquardt JU, Kleiner DE, Raggi C, Kitade M, Seo D, Akita H, Durkin ME, Thorgeirsson SS.

Gastroenterology. 2013 Jul;145(1):221-31. doi: 10.1053/j.gastro.2013.03.013. Epub 2013 Mar 19.


Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers.

Ochsner SA, Strick-Marchand H, Qiu Q, Venable S, Dean A, Wilde M, Weiss MC, Darlington GJ.

Stem Cells. 2007 Oct;25(10):2476-87. Epub 2007 Jul 19.


Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies.

Feo F, Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi D.

Crit Rev Oncog. 2000;11(1):19-62. Review.


Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors.

Kamino H, Yamazaki Y, Saito K, Takizawa D, Kakizaki S, Moore R, Negishi M.

Int J Oncol. 2011 Jun;38(6):1511-20. doi: 10.3892/ijo.2011.980. Epub 2011 Mar 17.


A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinoma.

Schröder PC, Segura V, Riezu JI, Sangro B, Mato JM, Prieto J, Santamaría E, Corrales FJ.

Funct Integr Genomics. 2011 Sep;11(3):419-29. doi: 10.1007/s10142-011-0230-7. Epub 2011 May 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk